QI PROGRAMS / MOC IV

Type 1 Diabetes (T1D) Screening and Referral Program

Ohio AAP has launched an exciting, multi-year quality improvement (QI) and education program for Type 1 Diabetes (T1D). This program will focus on improving screening and referrals for T1D and utilizing a new therapy designed to delay insulin dependence and reduce the risk of diabetic ketoacidosis (DKA).

About | Trainings | All Programs

Upcoming Trainings

General Information

The Type 1 Diabetes (T1D) Screening and Referral Program officially launched in December 2025, with funding secured through 2029.

This initiative is a hybrid quality improvement (QI) and education program, beginning in Ohio with plans for national expansion.

Staff & Leadership

  • Nicole Sheanon, MD, MS – Medical Director
  • Roni Christopher, DHSc, MEd, OT/L – Data/QI Consultant
  • Brooke Powell, CPhT – Program Manager

Trainings

Estimated Time to Complete Each Educational Activity: 1 hour

Original Release Date for CE/CME Credit: May 20, 2026
Expiration Date for CE/CME Credit: May 20, 2027
Media and Method of Participation in the Learning Process: Recorded webinar; the learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods: All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosures

Nicole Sheanon, MD, MS has the following relationships to disclose:

EnableSite PI for 4 AAb kit testing
MannKindAdvisory Board - Afrezza
SanofiAdvisory Board; Site PI for Freliximab and Beta Preserve
The other planners, faculty and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
Presenter Name:
Nicole Sheanon, MD, MS

Screen Today, Prevent DKA Tomorrow: Rewriting the Story of Type 1 Diabetes through Screening

Download the PowerPoint presentation. 

To claim CME/MOC Part II credit:

  • Watch the complete video
  • Click here to complete the MOC Part II evaluation and CME credit claiming form
    • Select “Screen Today, Prevent DKA Tomorrow: Rewriting the Story of Type 1 Diabetes through Screening” from the list of activities.
Review Enduring CME Information
Learning Objectives:
  1. Describe the stages of early‑stage Type 1 diabetes and recognize key clinical features associated with each stage.
  2. Explain the importance of screening for T1D, including who should be screened and the evidence supporting early detection.
  3. Identify available T1D screening options and outline the steps involved in the screening process.
  4. Discuss how early identification of T1D can improve outcomes and guide timely referral or intervention.
Target Audience: General pediatricians, family physicians, nurse practitioners, physician assistants

Accreditation Statement: The Ohio Chapter, American Academy of Pediatrics (Ohio AAP) is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

The Ohio AAP designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1 MOC point(s) in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Redefining the Type 1 Diabetes Timeline: Practical, Evidence-Based Approaches to Screening and Monitoring Early Disease

Download the PowerPoint presentation.

To claim CME/MOC Part II credit:

  • Watch the complete video
  • Click here to complete the MOC Part II evaluation and CME credit claiming form
    • Select “Redefining the Type 1 Diabetes Timeline: Practical, Evidence-Based Approaches to Screening and Monitoring Early Disease” from the list of activities.
Review Enduring CME Information
Learning Objectives:
  1. Describe the stages of early‑stage Type 1 Diabetes (T1D) and recognize key clinical features associated with each stage.
  2. Describe how early identification and monitoring of T1D can alter the disease timeline including impacts on clinical outcomes, family experience, and opportunities for intervention
  3. Participants will learn to apply evidence-based screening and staging strategies to identify and risk-stratify children with early-stage T1D.
  4. Describe how to implement appropriate monitoring for Early stage T1D to track progression and reduce risk of Diabetic Ketoacidosis (DKA).
  5. Describe how to incorporate disease-modifying therapies, including Teplizumab, into early T1D management.
Target Audience: Diabetes specialists, diabetes educators, general pediatricians, family physicians, nurse practitioners, physician assistants

Accreditation Statement: The Ohio Chapter, American Academy of Pediatrics (Ohio AAP) is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

The Ohio AAP designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1 MOC point(s) in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

T1D Webinar Registration (Primary Care) – Wednesday, December 9 @ Noon

National Education T1D Webinar #1 Registration (Primary Care)
What is your role? (Select all that apply)
Are you interested in participating in the Diabetes QI Program?

T1D Webinar Registration (Diabetes Specialists) – Thursday, December 10 @ Noon

National Education T1D Webinar #1 Registration (Diabetes Specialists)
What is your role? (Select all that apply)
Are you interested in participating in the Diabetes QI Program?
© Copyright - Ohio Chapter, American Academy of Pediatrics